Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

UK National Survey of Gastroenterologists’ attitudes and barriers toward therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease
Gaurav Nigam, Shadab Nayeemuddin, Evangelos Kontopantelis, et al.
Frontline Gastroenterology (2020) Vol. 12, Iss. 1, pp. 22-29
Open Access | Times Cited: 16

Showing 16 citing articles:

Meta‐analysis: The efficacy of therapeutic drug monitoring of anti‐TNF‐therapy in inflammatory bowel disease
Sonika Sethi, Shiluka Dias, Aditi Kumar, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 12, pp. 1362-1374
Open Access | Times Cited: 43
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Dahham Alsoud, Dirk Jan A. R. Moes, Zhigang Wang, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 3, pp. 291-308
Closed Access | Times Cited: 5
Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
Silvia Márquez-Megías, Ricardo Nalda‐Molina, Javier Sanz‐Valero, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1009-1009
Open Access | Times Cited: 26
Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: Availability, performance and barriers to implementation
Indy Sandaradura, Jan‐Willem C. Alffenaar, Menino Osbert Cotta, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 2, pp. 669-679
Open Access | Times Cited: 31
Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease
Johannes Stallhofer, Jan Guse, Miriam Kesselmeier, et al.
International Journal of Colorectal Disease (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
Therapeutic drug monitoring in inflammatory bowel disease: A practical approach
Devendra Desai
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 93-102
Closed Access | Times Cited: 2
An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease
Rajan Patel, Gaurav Nigam, Raj Jatale, et al.
Indian Journal of Gastroenterology (2020) Vol. 39, Iss. 2, pp. 176-185
Open Access | Times Cited: 21
Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases
Camilla de Almeida Martins, Karoline Soares Garcia, Natália Sousa Freitas Queiroz
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline
Letícia Kawano-Dourado, Eirik Klami Kristianslund, Dena Zeraatkar, et al.
BMJ (2024), pp. e079830-e079830
Closed Access | Times Cited: 2
Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis
Dena Zeraatkar, Tyler Pitre, Sarah Kirsh, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e000998-e000998
Open Access | Times Cited: 1
Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center Experience
Antony Raharja, Zehra Arkir, Giulia Rinaldi, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 9, pp. 1708-1716.e4
Open Access | Times Cited: 2
Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East
Gaurav Nigam, Kelly Chatten, Ala I. Sharara, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis
Yang Hu, Zaiwei Song, Yuan Gao, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 935-948
Open Access
Knowledge, Confidence, and Perception Toward Therapeutic Drug Monitoring Among Physicians and Pharmacists in Kuwait
Abdullah Albassam, Sarah S. Alghanem, Fahimah Al-Awadhi, et al.
Therapeutic Drug Monitoring (2022) Vol. 44, Iss. 4, pp. 511-519
Open Access | Times Cited: 2
Editorial: proactive anti‐TNF drug monitoring in IBD—Ready for the prime time? Authors' reply
Sonika Sethi, Aditi Kumar, Shiluka Dias, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 12, pp. 1455-1456
Open Access
Editorial commentary on the Indian Journal of Gastroenterology March–April 2020 issue
Jimmy K. Limdi
Indian Journal of Gastroenterology (2020) Vol. 39, Iss. 2, pp. 107-110
Open Access
Page 1

Scroll to top